Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
KBIO COMPANY Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩268.00 |
52 Week High | ₩453.00 |
52 Week Low | ₩225.00 |
Beta | -0.31 |
11 Month Change | 1.90% |
3 Month Change | 3.47% |
1 Year Change | -17.03% |
33 Year Change | -87.82% |
5 Year Change | -84.55% |
Change since IPO | -99.71% |
Recent News & Updates
KBIO (KOSDAQ:038530) Is In A Strong Position To Grow Its Business
Jul 16We're Not Worried About KBIO's (KOSDAQ:038530) Cash Burn
Mar 27Shareholder Returns
A038530 | KR Semiconductor | KR Market | |
---|---|---|---|
7D | -2.5% | -12.9% | -4.2% |
1Y | -17.0% | 8.7% | -2.7% |
Return vs Industry: A038530 underperformed the KR Semiconductor industry which returned 8.7% over the past year.
Return vs Market: A038530 underperformed the KR Market which returned -2.7% over the past year.
Price Volatility
A038530 volatility | |
---|---|
A038530 Average Weekly Movement | 12.8% |
Semiconductor Industry Average Movement | 7.8% |
Market Average Movement | 6.5% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A038530's share price has been volatile over the past 3 months.
Volatility Over Time: A038530's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 33 | Jong-Ju Lee | www.gold-pacific.com |
KBIO COMPANY Inc. engages in the bio distribution business. The company supplies experimental equipment and various reagents to general hospitals, universities, research institutes, etc.; and engages in distribution, bidding, equipment rental, and other business. It serves through online and offline stores.
KBIO COMPANY Inc. Fundamentals Summary
A038530 fundamental statistics | |
---|---|
Market cap | ₩30.95b |
Earnings (TTM) | -₩193.35m |
Revenue (TTM) | ₩48.29b |
0.6x
P/S Ratio-160.1x
P/E RatioIs A038530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A038530 income statement (TTM) | |
---|---|
Revenue | ₩48.29b |
Cost of Revenue | ₩41.70b |
Gross Profit | ₩6.59b |
Other Expenses | ₩6.78b |
Earnings | -₩193.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.67 |
Gross Margin | 13.64% |
Net Profit Margin | -0.40% |
Debt/Equity Ratio | 0% |
How did A038530 perform over the long term?
See historical performance and comparison